#BEGIN_DRUGCARD DB04818

# AHFS_Codes:
Not Available

# ATC_Codes:
N06AF05

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Ipronid
Iprozid
Marsilid
Propilniazida
Rivivol

# CAS_Registry_Number:
54-92-2

# ChEBI_ID:
Not Available

# Chemical_Formula:
C9H13N3O

# Chemical_IUPAC_Name:
N'-(propan-2-yl)pyridine-4-carbohydrazide

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 14:12:39 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.

# Dosage_Forms:
Not Available

# Drug_Category:
Antidepressive Agents
Monoamine Oxidase Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Small Molecule
Withdrawn

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
0.37

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Iproniazid

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13)

# InChI_Key:
InChIKey=NYMGNSNKLVNMIA-UHFFFAOYSA-N

# Indication:
For the treatment of depression (originally intended to treat tuberculosis).

# KEGG_Compound_ID:
C11777

# KEGG_Drug_ID:
D02579

# LIMS_Drug_ID:
4818

# Mechanism_Of_Action:
Not Available

# Melting_Point:
150 dec Â°C

# Molecular_Weight_Avg:
179.219

# Molecular_Weight_Mono:
179.105862053

# Organisms_Affected:
Humans and other mammals

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Iproniazid is a monoamine oxidase inhibitor (MAOI) that was developed as the first anti-depressant.

# Predicted_LogP_Hydrophobicity:
0.02

# Predicted_LogS:
-2.4

# Predicted_Water_Solubility:
6.74e-01 g/l

# Primary_Accession_No:
DB04818

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
3748

# PubChem_Substance_ID:
46505059

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C)NNC(=O)C1=CC=NC=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:44 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Iproniazid

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
MAOB

# Phase_1_Metabolizing_Enzyme_1_ID:
3939

# Phase_1_Metabolizing_Enzyme_1_Name:
Amine oxidase [flavin-containing] B

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Amine oxidase [flavin-containing] B
MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSY
VGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWR
TMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEV
SALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQ
TRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVY
YKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEER
LKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDR
IYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTT
FLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P27338

#END_DRUGCARD DB04818
